Therapeutic Asset Ratings

7,238 results matching 1 filter

109,449 assets · 8,383 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Retifanlimab Metastatic Malignant Neoplasm In The Colon	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (49)
Revumenib Leukemia	Memorial Sloan Kettering Cancer Center	P1/2	CCC (49)
Ribociclib Fallopian Tube Cancer	Avenzo Therapeutics, Inc.	P1/2	CCC (49)
shr2554 Lymphoma	Jiangsu HengRui Medicine Co., Ltd.	P1/2	CCC (49)
Sulfasalazine Glioblastoma	University of Zurich	P1/2	CCC (49)
Tcr-T Cells Hepatocellular Carcinoma	Lion TCR Pte. Ltd.	P1/2	CCC (49)
Tisagenlecleucel Leukemia	Stanford University	P1/2	CCC (49)
Tocilizumab Neoplasm	Hoffmann-La Roche	P1/2	CCC (49)
TRASTUZUMAB Esophageal Cancer	Institut Paoli-Calmettes	P1/2	CCC (49)
TRASTUZUMAB Head And Neck Squamous Cell Carcinoma	Fate Therapeutics	P1/2	CCC (49)
Vancomycin Melanoma	Microbiotica Ltd	P1/2	CCC (49)
(+)-VINCRISTINE Pancreatic Ductal Adenocarcinoma	Pfizer	P1/2	CCC (49)
Zanubrutinib Leukemia	Inhye Ahn	P1/2	CCC (49)
Zn-A-1041 HER2 Positive Breast Carcinoma	Suzhou Zanrong Pharma Limited	P1/2	CCC (49)
1-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-4-(4-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)-4-PIPERIDINOL Small Cell Lung Carcinoma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1/2	CCC (48)
1-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-4-(4-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)-4-PIPERIDINOL Cervical Small Cell Carcinoma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1/2	CCC (48)
161Tb-NYM032 Castration-Resistant Prostate Carcinoma	Zhengguo Chen	P1/2	CCC (48)
177lu-betabart Esophageal Squamous Cell Carcinoma	Radiopharm Theranostics, Ltd	P1/2	CCC (48)
177lu-betabart Head And Neck Squamous Cell Carcinoma	Radiopharm Theranostics, Ltd	P1/2	CCC (48)
177lu-betabart Small Cell Lung Carcinoma	Radiopharm Theranostics, Ltd	P1/2	CCC (48)
[177lu]lu-dpi-4452 Head And Neck Cancer	ITM Oncologics GmbH	P1/2	CCC (48)
[177lu]lu-dpi-4452 Infiltrating Bladder Urothelial Carcinoma	ITM Oncologics GmbH	P1/2	CCC (48)
[177lu]lu-dpi-4452 Kidney Neoplasm	ITM Oncologics GmbH	P1/2	CCC (48)
[177lu]lu-dpi-4452 Nonpapillary Renal Cell Carcinoma	ITM Oncologics GmbH	P1/2	CCC (48)
[177lu]lu-sn201 Cancer	Spago Nanomedical AB	P1/2	CCC (48)

Showing 776 to 800 of 7,238 assets

PreviousPage 32 of 290Next